LSKL, Inhibitor of Thrombospondin (TSP-1) (TFA)

Produktübersicht

• Artikelname: LSKL, Inhibitor of Thrombospondin (TSP-1) (TFA)
• Artikelnummer: TGM-TP2147
• Hersteller Artikelnummer: TP2147
• Alternativnummer: TGM-TP2147-5MG, TGM-TP2147-10MG, TGM-TP2147-25MG, TGM-TP2147-50MG, TGM-TP2147-100MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: H-Leu-Ser-Lys-Leu-NH2 TFA, LSKL, Inhibitor of Thrombospondin (TSP-1) (TFA), H-Leu-Ser-Lys-Leu-NH2 TFA(283609-79-0 TFA)

Produktbeschreibung

LSKL, Inhibitor of Thrombospondin (TSP-1) TFA, a tetrapeptide derived from latency-associated protein (LAP)-TGFbeta, acts as a competitive antagonist of TGF-beta1.

Produkteigenschaften

• Molekulargewicht: 572.62
• Formel: C23H43F3N6O7
• Target-Kategorie: TGF-beta/Smad